Skip to main content
. 2019 Dec 2;2019:8421479. doi: 10.1155/2019/8421479

Figure 1.

Figure 1

Circulatory Tfh and Tfr cells in patients with antineutrophil cytoplasmic antibody- (ANCA-) associated vasculitis (AAV). (a) The gate strategy for circulatory Tfh and Tfr cells. The percentage and count of circulatory Tfh (b, c) and Tfr (d, e) cells and Tfh/Tfr ratios (f) in patients with AAV and healthy controls. (g) Mean fluorescence intensity (MFI) of FOXP3 in Tfh and Tfr cells. ∗∗P < 0.01. Tfh: T follicular helper cells; Tfr: T follicular regulatory cells.